High Level of Tobacco Carcinogen–Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers

Exposure to tobacco-specific nitrosamines (TSNA) and polycyclic aromatic hydrocarbons (PAH) is recognized to play an important role in the development of oral/head and neck squamous cell cancer (HNSCC). We recently reported higher levels of TSNA-associated DNA adducts in the oral cells of smokers with HNSCC as compared with cancer-free smokers. In this study, we further investigated the tobacco constituent exposures in the same smokers to better understand the potential causes for the elevated oral DNA damage in smokers with HNSCC. Subjects included cigarette smokers with HNSCC (cases, n = 30) and cancer-free smokers (controls, n = 35). At recruitment, tobacco/alcohol use questionnaires were completed, and urine and oral cell samples were obtained. Analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and N'-Nitrosonornicotine (NNN; TSNA biomarkers), 1-hydroxypyrene (1-HOP, a PAH), cotinine, 3′-hydroxycotinine, and the nicotine metabolite ratio (NMR) were performed. Cases and controls differed in mean age, male preponderance, and frequency of alcohol consumption (but not total alcoholic drinks). Univariate analysis revealed similar levels of NNN, 1-HOP, and cotinine between groups but, as reported previously, significantly higher DNA adduct formation in the cases. Multiple regression adjusting for potential confounders showed persistent significant difference in DNA adduct levels between cases and controls [ratio of geometric means, 20.0; 95% CI, 2.7–148.6). Our cohort of smokers with HNSCC demonstrates higher levels of TSNA-derived oral DNA damage in the setting of similar exposure to nicotine and tobacco carcinogens. Among smokers, DNA adduct formation may act as a predictor of eventual development of HNSCC that is independent of carcinogen exposure indicators. Cancer Prev Res; 10(9); 507–13. ©2017 AACR. See related editorial by Johnson and Bauman, p. 489

[1]  B. Lindgren,et al.  Optimized Liquid Chromatography Nanoelectrospray-High-Resolution Tandem Mass Spectrometry Method for the Analysis of 4-Hydroxy-1-(3-pyridyl)-1-butanone-Releasing DNA Adducts in Human Oral Cells. , 2016, Chemical research in toxicology.

[2]  S. Hecht,et al.  Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines. , 2016, Accounts of chemical research.

[3]  Delshanee Kotandeniya,et al.  Combined analysis of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Stephen S Hecht,et al.  Self‐reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer , 2015, The Laryngoscope.

[5]  Jian-Min Yuan,et al.  Tobacco‐specific N‐nitrosamine exposures and cancer risk in the Shanghai cohort study: Remarkable coherence with rat tumor sites , 2014, International journal of cancer.

[6]  S. Hecht,et al.  (S)-N'-Nitrosonornicotine, a constituent of smokeless tobacco, is a powerful oral cavity carcinogen in rats. , 2013, Carcinogenesis.

[7]  S. Hecht,et al.  High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. , 2013, Chemical research in toxicology.

[8]  D. Hatsukami,et al.  Elevated levels of 1‐hydroxypyrene and N′‐nitrosonornicotine in smokers with head and neck cancer: A matched control study , 2013, Head & neck.

[9]  K. Christensen,et al.  Age and gender effects on DNA strand break repair in peripheral blood mononuclear cells , 2013, Aging cell.

[10]  D. Hatsukami,et al.  Analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing DNA adducts in human exfoliated oral mucosa cells by liquid chromatography-electrospray ionization-tandem mass spectrometry. , 2013, Chemical research in toxicology.

[11]  Stephen S Hecht,et al.  Lung carcinogenesis by tobacco smoke , 2012, International journal of cancer.

[12]  Anil Kumar,et al.  Ethanol-Mediated Regulation of Cytochrome P450 2A6 Expression in Monocytes: Role of Oxidative Stress-Mediated PKC/MEK/Nrf2 Pathway , 2012, PloS one.

[13]  Jian-Min Yuan,et al.  Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. , 2011, Carcinogenesis.

[14]  Amy Y. Chen,et al.  Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis , 2011, Oncology.

[15]  S. Hecht,et al.  Quantitation of a minor enantiomer of phenanthrene tetraol in human urine: correlations with levels of overall phenanthrene tetraol, benzo[a]pyrene tetraol, and 1-hydroxypyrene. , 2011, Chemical research in toxicology.

[16]  S. Hecht,et al.  Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. , 2009, Cancer research.

[17]  Jian-Min Yuan,et al.  Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. , 2009, Cancer research.

[18]  A. Heling,et al.  Ultrasensitive method for the determination of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts by gas chromatography–high resolution mass spectrometry in mucosal biopsies of the lower esophagus , 2009, Analytical and bioanalytical chemistry.

[19]  T. Church,et al.  A Prospectively Measured Serum Biomarker for a Tobacco-Specific Carcinogen and Lung Cancer in Smokers , 2009, Cancer Epidemiology Biomarkers & Prevention.

[20]  L. von Meyer,et al.  4-Hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in lung, lower esophagus and cardia of sudden death victims. , 2008, Toxicology.

[21]  E. Richter,et al.  Mass spectrometric analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in human lung. , 2007, Toxicology.

[22]  S. Hecht,et al.  Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. , 2005, Chemical research in toxicology.

[23]  N. Benowitz,et al.  Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity , 2004, Clinical pharmacology and therapeutics.

[24]  S. Hecht,et al.  Improved method for determination of 1-hydroxypyrene in human urine. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  E. Park,et al.  Does Enhancing Partner Support and Interaction Improve Smoking Cessation? A Meta-Analysis , 2004, The Annals of Family Medicine.

[26]  C. Pomerleau,et al.  Nicotine metabolite ratio as a predictor of cigarette consumption. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[27]  Shana J Sturla,et al.  Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. , 2003, Chemical research in toxicology.

[28]  E. Loechler,et al.  Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. , 2000, Mutation research.

[29]  Faten Gad,et al.  Mechanisms and implications of the age‐associated decrease in DNA repair capacity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  M. Yamada,et al.  Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. , 2000, Carcinogenesis.

[31]  S. Hecht,et al.  Effects of watercress consumption on urinary metabolites of nicotine in smokers. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  D. Hatsukami,et al.  Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. , 1999, Cancer research.

[33]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[34]  F. Chung,et al.  1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. , 1998, Cancer research.

[35]  S. Nesnow,et al.  Mechanistic relationships between DNA adducts, oncogene mutations, and lung tumorigenesis in strain A mice. , 1998, Experimental lung research.

[36]  N. J. Jones,et al.  Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies. , 1995, Cancer research.

[37]  E. S. Gillespie,et al.  An investigation of mutation as a function of age in humans. , 1994, Mutation research.

[38]  P. J. Mayer,et al.  Gender differences in age-related decline in DNA double-strand break damage and repair in lymphocytes. , 1991, Annals of human biology.

[39]  J. Resau,et al.  Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. , 1991, Chemical research in toxicology.

[40]  S. Hecht,et al.  Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine. , 1988, Carcinogenesis.

[41]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.